Ramos MC de A, Folgueira MAAK, Maistro S, Campolina AG, Soárez PC de, Bock GH de, et al. Cost effectiveness of the cancer prevention program for carriers of the BRCA1/2 mutation. Rev. saúde pública [Internet]. 2018 Nov. 22 [cited 2024 Oct. 2];52:94. Available from: https://periodicos.usp.br/rsp/article/view/152004